CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishBACCARANI, MICHELE
Risultati 1 - 20 di 465 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 1 | Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome. | Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M. | 2010 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1.01 Articolo in rivista | |
| 2 | You have accessClinical Relevance of Low Burden BCR-ABL1 Mutations Detectable By Amplicon Deep Sequencing (DS) in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients (pts): The Type of Mutation Matters | Soverini, Simona; DE BENEDITTIS, Caterina; Venturi, Claudia; Papayannidis, Cristina; Mancini, Manuela; Machova Polakova, Katerina; Russo, Domenico; Bresciani, Paola; Iurlo, Alessandra; Abruzzese, Elisabetta; Sorà, Federica; Baccarani, Michele; Cavo, Michele; Haferlach, Torsten; Martinelli, Giovanni | 2015 | BLOOD | 1.06 Abstract in rivista | |
| 3 | WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia. | Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G. | 2007 | LEUKEMIA | 1.01 Articolo in rivista | |
| 4 | VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly. | Fina M; Tani M; Stefoni V; Musuraca G; Marchi E; Pellegrini C; Alinari L; Derenzini E; Bacci F; Pileri S; Baccarani M; Zinzani PL. | 2007 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | |
| 5 | Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 years | Palandri F.; Polverelli N.; Catani L.; Ottaviani E.; Baccarani M.; Vianelli N. | 2012 | BRITISH JOURNAL OF HAEMATOLOGY | 1.01 Articolo in rivista | |
| 6 | Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. | Marzocchi G.; Castagnetti F.; Luatti S.; Baldazzi C.; Stacchini M.; Gugliotta G.; Amabile M.; Specchia G.; Sessarego M.; Giussani U.; Valori L.; Discepoli G.; Montaldi A.; Santoro A.; Bonaldi L.; Giudici G.; Cianciulli A.M.; Giacobbi F.; Palandri F.; Pane F.; Saglio G.; Martinelli G.; Baccarani M.; Rosti G.; Testoni N. | 2011 | BLOOD | 1.01 Articolo in rivista | |
| 7 | Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. | Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Baccarani M; Zinzani PL | 2005 | LEUKEMIA & LYMPHOMA | 1.01 Articolo in rivista | |
| 8 | Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies | Soverini S.; Gnani A.; De Benedittis C.; Castagnetti F.; Gugliotta G.; Bochicchio MT.; Palandri F.; Arpinati M.; Bonifazi F.; Abruzzese E.; Sorà F.; Alimena G.; Pregno P.; Specchia G.; Russo D.; Pane F.; Saglio G.; Salvucci M.; Zaccaria A.; Poletti G.; Giannini B.; Iacobucci I.; Lonetti A.; Durante S.; Rosti G.; Baccarani M.; Martinelli G. | 2011 | BLOOD | 4.02 Riassunto (Abstract) | |
| 9 | Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | 4.02 Riassunto (Abstract) | |
| 10 | Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain. | Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G. | 2013 | BLOOD | 1.01 Articolo in rivista | |
| 11 | Ultradeep-Amplicon Pyrosequencing for Mutation Detection in the Kinase Domain of BCR-ABL Revealed Artificial Low-Level Variants That Need to Be Avoided for Relevant Mutational Data Interpretation | Adela Brouckova; Simona Soverini; Caterina De Benedittis; Hana Klamova; Cyril Salek; Marek Trneny; Michele Baccarani; Giovanni Martinelli; Katerina Machova Polakova | 2012 | BLOOD | 4.02 Riassunto (Abstract) | |
| 12 | Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies | Soverini, Simona; DE BENEDITTIS, Caterina; Machova Polakova, Katerina; Brouckova, Adela; Papayannidis, Cristina; Bresciani, Paola; Coluccio, Valeria; Iacobucci, Ilaria; Venturi, Claudia; Luppi, Mario; Ottaviani, Emanuela; Cattina, Federica; Foà, Robin; Vitale, Antonella; Russo, Domenico; Baccarani, Michele; Martinelli, Giovanni | 2012 | BLOOD | 1.06 Abstract in rivista | |
| 13 | Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy | Soverini, Simona; DE BENEDITTIS, Caterina; Machova Polakova, Katerina; Brouckova, Adela; Castagnetti, Fausto; Gugliotta, Gabriele; Palandri, Francesca; Papayannidis, Cristina; Iacobucci, Ilaria; Venturi, Claudia; Mancini, Manuela; Leo, Elisa; Klamova, Hana; Paolini, Stefania; Russo, Domenico; Rosti, Gianantonio; Baccarani, Michele; Cavo, Michele; Martinelli, Giovanni | 2013 | BLOOD | 1.06 Abstract in rivista | |
| 14 | Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives | Malagola, Michele; Papayannidis, Cristina; Baccarani, Michele | 2016 | ANNALS OF HEMATOLOGY | 1.01 Articolo in rivista | |
| 15 | Tyrosine kinase inhibitors in chronic myeloid leukaemia: Which, when, for whom? | Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Baccarani, Michele | 2017 | NATURE REVIEWS. CLINICAL ONCOLOGY | 1.01 Articolo in rivista | |
| 16 | Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: A phase 1 safety and pharmacokinetics study | Martinelli, Giovanni; Oehler, Vivian G.; Papayannidis, Cristina; Courtney, Rachel; Shaik, M. Naveed; Zhang, Xiaoxi; O'Connell, Ashleigh; Mclachlan, Karen R.; Zheng, Xianxian; Radich, Jerald; Baccarani, Michele; Kantarjian, Hagop M.; Levin, Wendy J.; Cortes, Jorge E.; Jamieson, Catriona | 2015 | THE LANCET. HAEMATOLOGY | 1.01 Articolo in rivista | |
| 17 | TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA | Michele Baccarani;Fausto Castagnetti;Gabriele Gugliotta;Francesca Palandri;Gianantonio Rosti | 2014 | MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 1.01 Articolo in rivista | |
| 18 | Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response | Palandri F; Iacobucci I; Soverini S; Castagnetti F; Poerio A; Testoni N; Alimena G; Breccia M; Rege-Cambrin G; Tiribelli M; Varaldo R; Abruzzese E; Martino B; Luciano L; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G. | 2009 | CLINICAL CANCER RESEARCH | 1.01 Articolo in rivista | |
| 19 | Treatment of patients with the hypereosinophilic syndrome with mepolizumab. | Rothenberg, Me; Klion, Ad; Roufosse, Fe; Kahn, Je; Weller, Pf; Simon, Hu; Schwartz, Lb; Rosenwasser, Lj; Ring, J; Griffin, Ef; Haig, Ae; Frewer, Pi; Parkin, Jm; Gleich, Gj; Mepolizumab HES Study Group, (; Baccarani, M; ), | 2008 | NEW ENGLAND JOURNAL OF MEDICINE | 1.01 Articolo in rivista | |
| 20 | Treatment and outcome of 2904 CML patients from the EUTOS population-based registry | Hoffmann, V.S; Baccarani, M.; Hasford, J.; Castagnetti, F.; Di Raimondo, F.; Casado, L.F.; Turkina, A.; Zackova, D.; Ossenkoppele, G.; Zaritskey, A.; Höglund, M.; Simonsson, B.; Indrak, K.; Sninska, Z.; Sacha, T.; Clark, R.; Bogdanovic, A.; Hellmann, A.; Griskevicius, L.; Schubert-Fritschle, G.; Sertic, D.; Guilhot, J.; Lejniece, S.; Zupan, I.; Burgstaller, S.; Koskenvesa, P.; Everaus, H.; Costeas, P.; Lindoerfer, D.; Rosti, G.; Saussele, S.; Hochhaus, A.; Hehlmann, R. | 2017 | LEUKEMIA | 1.01 Articolo in rivista |
Nome completo:
BACCARANI, MICHELE
Copyright © 2019